Navigation Links
Spherix Announces 2008 Financial Results
Date:3/30/2009

BETHESDA, Md., March 30 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today reported results for the year ended December 31, 2008.

Recent Company Highlights

  • Biospherics
    • Naturlose(R) Phase 3 clinical trial investigating efficacy as a treatment for Type 2 diabetes continues on schedule; completion expected in mid-2010
    • Interim data results expected in third quarter of 2009
    • Completion of the related Phase 2 Dose Range trial expected in 2009
    • Peer-reviewed publication of new results from animal studies

  • Spherix Consulting
    • Revenue from health sciences consulting services has grown every quarter since its start in July 2007
    • Additional consulting staff hired to handle increased demand

"The next few months will be an exciting time for Spherix and its shareholders," stated Dr. Claire L. Kruger, CEO of Spherix. "The Company anticipates sharing interim data in the fall from its ongoing Phase 3 clinical trial investigating the efficacy of Naturlose as a novel treatment for Type 2 diabetes. I am pleased to report that Spherix will be holding its first earnings webcast on April 2, during which we will provide our shareholders and other interested parties with additional information and updates on both the Biospherics and Spherix Consulting subsidiaries."

Financial Results for the Year Ended 2008


'/>"/>

SOURCE Spherix Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. Spherix Reports 3rd Quarter Earnings
3. Spherix Reports 2007 Financial Results
4. Spherix Hires Key Employees
5. Spherix Holds Annual Shareholders Meeting
6. Spherix Reports 1st Quarter Earnings
7. Spherix Receives NASDAQ Bid Price Deficiency Letter
8. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
9. Spherix Transfers Stock Listing to Nasdaq Capital Market
10. Spherix Reports 3rd Quarter Earnings
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... ATCC, the premier global biological materials ... important appointments to the senior leadership team. Barbie Bigelow ... and Technology and Dr. Maryellen de Mars also joins ... Both roles are new positions at ATCC. ... at ATCC described the additions as part of a ...
(Date:9/23/2014)... 2014  Age Defying Dermatology ® , owned and ... one of the first clinics in the Bay Area ... for tattoo removal. The treatment safely and effectively erases ... tattoo removal has been a lengthy, painful, and all ... an opportunity to erase tattoo pigment more efficiently with ...
(Date:9/23/2014)... , Sept. 23, 2014   GenoSpace , ... comprehensive suite of tools to enable the broad use ... announced that it has been awarded Phase I of ... from the National Institutes of Health (NIH) to enable ... Logo - http://photos.prnewswire.com/prnh/20140922/147649 ...
(Date:9/23/2014)... 2014 Healthcare professionals, patients ... convene at the Society for Integrative Oncology ... October 26-28 in Houston, Texas to discuss ... in individualized integrative cancer care. This multi-disciplinary ... nutritionists, naturopaths, acupuncturists, and other complementary care ...
Breaking Biology Technology:ATCC Announces New Appointments to its Leadership Team 2ATCC Announces New Appointments to its Leadership Team 3Age Defy Now Offers World's Most Advanced Technology for Tattoo Removal 2GenoSpace Awarded Fast Track SBIR Grant to Enable Data Access and Cohort Construction for Biorepositories 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 3
... ... biotechnology, ... Sciences today announced a partnership under which,Metahelix will assist in ... expert technological guidance,regarding usage. The efforts of this collaboration will ...
... Market Research, a,global provider of pharmaceutical competitive ... report providing critical strategic insight,for pharma and ... market for Rheumatoid,Arthritis (RA) therapies., In ... Analysis: Rheumatoid,Arthritis Q2 2008, MedPredict,s global Thought ...
... Arete Therapeutics Inc., a,privately-held biopharmaceutical company developing first-in-class ... of,James Sabry, M.D., Ph.D., as president and chief ... and member of the board of directors,since March ... position of,president and chief executive officer, who will ...
Cached Biology Technology:Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences 2Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences 3New MedPredict Report Highlights Trend Toward Early Diagnosis and Treatment of Rheumatoid Arthritis, Impact on Pharmaceutical Development 2Arete Therapeutics Names James Sabry, M.D., Ph.D., President and Chief Executive Officer 2
(Date:9/23/2014)... organisms, including humans, have parasitic DNA fragments called "jumping ... instructions in the process. And that phenomenon can result ... the University of Rochester now report that the "jumping ... when a multi-function protein stops keeping them in check ... In a study published today in Nature Communications ...
(Date:9/22/2014)... Yale University researchers are studying a potential new ... respiratory disease in which scars develop in the lungs ... microRNA mimic, miR-29, which is delivered to lung tissue ... fibrosis, it reversed fibrosis after several days. , ... EMBO Molecular Medicine . , "The mimic, when ...
(Date:9/22/2014)... by-products such as straw could be made quicker and ... UK and France. , Researchers funded by the ... variant straw plants whose cell walls are more easily ... significantly smaller or weaker than regular plants. , ... security as biofuels from non-food crops become easier and ...
Breaking Biology News(10 mins):A multi-function protein is key to stopping genomic parasites from 'jumping' 2Reversing the effects of pulmonary fibrosis 2Plant variants point the way to improved biofuel production 2
... protein 'wiring' that differs markedly from the cellular circuitry ... to the development of antimalarial drugs that exploit that ... parasite responsible for an estimated 1 million deaths per ... markedly from the cellular circuitry of other higher organisms, ...
... discovery in basic plant biology that may set the stage ... scientists have identified for the first time a protein that ... toxin to kill the cell. It had been known that ... plant cells, but never before has a protein been found ...
... University have successfully cultured in a laboratory a microorganism with ... advance that may ultimately help shed light on the ecology ... smallest free living cell known and probably the most abundant ... time to study the SAR11 "proteorhodopsin" gene in a laboratory, ...
Cached Biology News:Researchers develop new method to help find deadly malaria parasite's Achilles heel 2Researchers develop new method to help find deadly malaria parasite's Achilles heel 3Biologists discover new pathway into plant cells 2Biologists discover new pathway into plant cells 3Odd energy mechanism in bacteria analyzed 2